A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Background Recent studies have revealed that liver receptor homolog 1 (LRH1) plays a vital role in several human cancers, but its role in ovarian cancer (OC) remains unclear. We aimed to investigate whether LRH1 protein can act as a promising biomarker to predict the prognosis and metastasis in OC patients.Methods LRH1 expression status was evaluated by immunohistochemical and reverse transcription (RT)-qPCR analysis. The effects of LRH1 on tumor cell proliferation and progression weredoi:10.21203/rs.3.rs-26942/v1 fatcat:4u2lwfmlxzbdtnnsdyox6zawxe